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Introduction
Areca nut (AN) is the fruit seed of the palm tree Areca
catechu, which is often mixed with betel quid and used as a
masticatory substance by approximately 600 million people
worldwide [14]. AN is consumed by people of all age
groups, and chewing AN is a popular habit in Asian and
Oceanic countries. It is considered to be commonly used as
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Areca nut (AN) chewing is a habit in many countries in Central, Southern, and Southeast Asia.
It is strongly associated with the occurrence of oral, pharyngeal, and esophageal cancer as well
as systemic inflammation. However, the association between AN intake and the development
of gastric lesions has not yet been identified. The aim of this study was to investigate the effect
of AN on gastric diseases using a mouse model for Helicobacter pylori infection. We studied
four groups of mice: those fed a normal diet (ND), those fed a diet containing 2.5% AN (AD),
those fed ND and infected with H. pylori PMSS1 strain (ND/HP), and those fed AD and
infected with H. pylori PMSS1 strain (AD/HP). Food intake and body weight were monitored
weekly during the experiments. At 10 weeks, the mice were sacrificed, and the stomach
weight, H. pylori colonization, and gastric inflammation were evaluated. The stomach weight
had increased significantly in the ND/HP and AD/HP groups along with increases in
H. pylori colonization; however, there was no significant difference between these two groups
with respect to stomach weight and colonization. On histological grading, mononuclear cell
infiltration was severer in the AD/HP group than in the ND/HP group. These data suggest
that chronic gastric inflammation was aggravated by AN treatment in the mice with H. pylori-
induced gastric lesions. Furthermore, as previously suggested, this animal model is useful to
determine the effect of potential carcinogens on gastric lesions induced by H. pylori infection.
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a psychoactive substance, such as tobacco, alcohol, and
caffeine [24], and its constituents include carbohydrate, fat,
protein, crude fiber, polyphenols (such as flavonol and
tannin), alkaloid, and mineral matter [21]. Systemic effects
of AN are mainly due to its principal alkaloid, arecoline
[12]. Previous studies have shown that AN chewers have a
higher prevalence of periodontal diseases and of oral,
pharyngeal and esophageal cancers [16]. Recently, it has
also been reported that chewing AN may increase the risk
of systemic inflammation [28]. 
Helicobacter pylori is a microaerophilic gram-negative
spiral-shaped bacterium found in the human stomach.
H. pylori is the major causative agent in chronic gastritis
and peptic ulcer disease as well as a cause of gastric cancers
[17]. An association between H. pylori infection and the
development of gastric disease is also found in studies
using animal models [2, 10, 11, 22]. Among these models,
the mouse model using H. pylori strain PMSS1 is widely
used [2, 20, 27]. Fernando et al. [8] suggested that chewing
betel quid that contains AN and lime, with or without
tobacco, may predispose persons infected with H. pylori to the
development of severe gastric diseases, including gastric
cancers, as a result of chewing and swallowing this
substance. Thus, to identify an association between AN
intake and H. pylori-induced gastric disease, we investigated
the effects of AN on gastric lesions and on bacterial
colonization in mice infected with the H. pylori PMSS1
strain.
Materials and Methods
Diet Preparation 
AN was provided by the University of Peradeniya, Sri Lanka.
Dried AN was finely powdered and mixed with a normal diet
AIN76A (Research Diets, USA) at a concentration of 2.5% (w/w)
in Gwangju Institute of Science and Technology, Korea. The diet
containing AN was pelleted, sealed, and stored at 4°C until use.
Animal Experiments
We purchased 5-week-old male C57BL/6 mice from Orient Bio
Inc. (Korea). The animals were maintained in a temperature-
controlled room at 22°C, with a 12 h light-dark cycle. Food and
water were provided ad libitum. After 1 week of acclimation, 34
mice were divided into four groups: those fed a normal diet (the
ND group) (n = 6), those fed a diet containing 2.5% AN (the AD
group) (n = 8), those fed a normal diet and infected with H. pylori
PMSS1 strain (the ND/HP group) (n = 10), and those fed a diet
containing 2.5% AN and infected with H. pylori PMSS1 strain (the
AD/HP group) (n = 10) (Fig. 1).
At 6 weeks after intragastric inoculation with H. pylori PMSS1
strain, the mice in the ND/HP and AD/HP groups were fed the
AIN76A diet and the AIN76A diet containing 2.5% AN,
respectively, for 10 weeks. As a negative control, ND mice and
AD mice that received Brucella broth were fed the AIN76A diet.
The body weight and food intake were measured every week
during the experimental period. At the end of this period, the
mice were sacrificed, gastric mucosal tissues were weighed and
examined histologically, and H. pylori colonization was determined,
as described below. The animal experiments were performed in
accordance with institutional guidelines, and protocols were
approved by the animal ethics committee of the Yonsei University
College of Dentistry in Seoul, Korea (2012-0076).
H. pylori Culture and Infection of Mice
The H. pylori PMSS1 strain was stored as frozen stock at -80°C
in brain–heart infusion medium supplemented with 20% glycerol
and 10% fetal bovine serum (FBS; Gibco-BRL, USA). H. pylori was
grown on horse blood agar plates containing 4% Columbia blood
agar base (Oxoid, Basingstoke, UK), 5% defibrinated horse blood
(Hemostat Laboratories, Dixon, CA, USA), 0.2% β-cyclodextrin,
10 μg/ml of vancomycin, 2.5 U/ml of polymyxin B, 5 μg/ml of
trimethoprim, and 8 μg/ml of amphotericin B at 37°C under
microaerobic conditions. A microaerobic atmosphere was generated
using a CampyGen sachet (Oxoid) in a GasPak jar (BD, USA). For
liquid culture, H. pylori was grown in Brucella broth (Difco & BBL
Diagnostics, USA) containing 10% FBS and 10 μg/ml of vancomycin.
Cultures were shaken in a microaerobic environment. According
to the growth curve, 2 × 107 bacteria were collected and resuspended
in 250 μl of Brucella broth, which was introduced via intragastric
gavage to produce infection after the mice had fasted for 24 h. 
Determining the Number of Viable H. pylori in the Stomach
The number of viable H. pylori colonies in the stomachs of the
mice was determined as previously described, with minor
Fig. 1. Experimental design. 
Mice in the ND group were inoculated with Brucella broth (▽) and
fed a normal diet (□ ). The AD group of mice was inoculated with
Brucella broth and fed a diet containing 2.5% AN (■ ). The ND/HP
group was inoculated with H. pylori strain PMSS1 (▼ ) and fed a
normal diet. The AD/HP group was inoculated with H. pylori strain
PMSS1 and fed a diet containing 2.5% AN. 
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modifications [29]. After the mice had fasted for 18 h, they were
euthanized, and their stomachs were excised. The stomach was
dissected along the greater curvature, the forestomach was
removed, and the stomachs were washed with 0.01 M of
phosphate-buffered saline (pH 7.4) and then divided into two
halves longitudinally. One half of each stomach was homogenized
in 1 ml of Brucella broth using a homogenizer (Kinematica,
Switzerland). The diluted homogenates were applied to horse
blood agar plates used to culture H. pylori and were supplemented
with 100 μg/ml of vancomycin, 100 μg/ml of bacitracin, and
10 μg/ml of nalidixic acid. The plates were incubated at 37°C
under microaerobic conditions for 5 days. The colonies were
counted, and the number of viable H. pylori was expressed as
colony-forming units (CFU) per gram of stomach tissue.
Histological Analysis
The remaining half of each stomach was fixed in 10% neutral
buffered formalin and embedded in paraffin. The paraffin was cut
into 4 μm sections and stained with hematoxylin and eosin for
morphological observation. Two aspects of gastric lesions were
recorded according to the updated Sydney system: the infiltration
of polymorphonuclear leukocytes (PMNs) and chronic inflammation
based on mononuclear cell infiltration. Morphological features of
the gastric antrum and corpus were graded on a scale of 0 to 4:
Grade 0, normal; Grade 1, slight; Grade 2, mild; Grade 3,
moderate; and Grade 4, severe [7]. Microscopic images were
obtained at magnifications of ×100 for the corpus and ×200 for the
antrum.
Statistical Analysis
The SPSS statistics ver. 23 program (IBM, USA) was used for all
statistical analyses. Analysis of variance was used to compare
different groups, and multiple comparisons were performed using
Scheffé’s method. A p-value of <0.05 was regarded as statistically
significant.
Results
Gross Changes in Food Intake and Body Weight of Mice
We measured the food intake and body weight of the
mice over 10 weeks to determine whether feeding AN
caused any gross changes in these values. During this
period, food intake was similar in all four groups of mice
(Fig. 2A). The body weight increased in the AD group as
compared with the ND group (Fig. 2B). Thus, importantly,
the ND/HP and AD/HP groups showed no difference in
either food intake or weight gain. 
Effect of AN on Viable H. pylori Colonization in the Mouse
Stomach
To determine the effect of AN on H. pylori colonization in
the gastric mucosa of mice, the number of H. pylori colonies
was measured at 10 weeks after the mice had been fed the
normal or AN-containing diet. Obviously, the ND/HP and
AD/HP groups infected with H. pylori showed a significant
increase in H. pylori colonization as compared with the ND
and AD groups without H. pylori infection (Fig. 3A).
However, there was no significant difference between the
ND/HP and AD/HP groups infected with H. pylori,
suggesting that AN treatment had no effect on H. pylori
colonization.
Effect of AN on Stomach Weight of H. pylori-Infected Mice
To determine the effect of AN on the stomach weight of
the mice infected with H. pylori, the stomachs were weighed
at 10 weeks after the mice had been fed either the normal or
the AN-containing diet, with results expressed as the ratio
of stomach weight to body weight. The stomach weight in
Fig. 2. Gross changes in food intake and body weight in mice during the experimental period. 
(A) Food intake change. (B) Body weight change. Data are presented as the means ± SD. * indicates a significant difference at p < 0.05.
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the ND/HP and AD/HP groups infected with H. pylori
was significantly increased (Fig. 3B); however, there was no
significant difference between these two groups, suggesting
that AN treatment did not affect gross stomach weight.
Effect of AN on Gastric Lesions of H. pylori-Infected Mice
To determine whether AN affects H. pylori-induced gastric
lesions, we observed the histopathological changes (i.e.,
infiltration of PMNs and mononuclear cells) in the corpus
and antrum (Figs. 4A and 4B). Although PMN infiltration
was similar in all four groups of mice, mononuclear cell
infiltration was significantly increased in the ND/HP and
AD/HP groups as compared with the mice in non-infected
groups (Figs. 4C and 4D). More importantly, the mononuclear
cell infiltration was more severe in the AD/HP group than
in the ND/HP group (Fig. 4D). In addition, it is worth
noting that no hyperplastic or metaplastic lesions were
observed in any group throughout the experimental period.
Discussion
The distinctive characteristic of H. pylori infection is
chronic gastric inflammation [26]. Various animal models
have been employed to investigate human H. pylori infection.
Recently, it was reported that certain H. pylori strains were
able to colonize the gastric mucosa of mice [23] and of
Mongolian gerbils [30]. Of the several animal models
infected with H. pylori, mice appear to have mild responses
in terms of gastric inflammation [9]. The commonly used
mouse-adapted strain is H. pylori SS1, which does not
translocate cytotoxin-associated gene A (CagA), a virulence
factor, into the host cells or induce interleukin (IL)-8 [6].
Since the presence of the functional CagA in H. pylori
strains is associated with more severe gastric inflammation
and the development of neoplastic gastric disease [4, 26],
the H. pylori PMSS1 strain with a functional CagA in vivo
system has been employed for the mouse model [2].
In this mouse study, this PMSS1 strain induced moderate
chronic inflammation in the animals’ gastric mucosa. This
finding suggests that the mice infected with the H. pylori
PMSS1 strain probably mimic the human’s asymptomatic
response to CagA-positive H. pylori infection. Furthermore,
the pre-neoplastic lesions such as glandular hyperplasia
and metaplasia were not observed during the period of
H. pylori infection. To develop pre-neoplastic lesions, it might
be necessary for a more long-term infection or infection
combined with exposure to carcinogens such as AN.
Among the mice without H. pylori infection, those fed AD
showed no inflammatory changes as compared with the
control ND group during the experimental period. In
contrast, in the presence of H. pylori infection, the mice fed
AD showed more severe lymphocyte infiltration than did
the ND/HP group fed a normal diet in the presence of
H. pylori infection. Previous studies have reported that AN
extracts increase the expression of inflammatory cytokines
such as tumor necrosis factor-α, IL-1β, IL-6, and IL-8 [5], and
H. pylori induces the increased production of pro-
inflammatory cytokines [13, 15]. Combined with these
findings, our data suggest that AN treatment aggravates
H. pylori-induced gastritis by inducing the increased
Fig. 3. Viable number of H. pylori colonies in the gastric mucosa, and the ratio of stomach weight to body weight in the H. pylori-
infected mice. 
(A) Viable H. pylori colonization was evaluated by means of a whole stomach culture system. (B) Stomachs were weighed at 10 weeks after the
mice were fed a normal or AN-containing diet, and results were expressed as the ratio of stomach weight to body weight in the H. pylori-infected
mice. * indicates a significant difference at p < 0.05.
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expression of inflammatory cytokines in the gastric mucosa.
Considering that fewer than 10% of patients with
H. pylori infection have symptomatic gastric disease, it can
be assumed that AN may affect disease progression from
asymptomatic infection to severe gastric disease. Because
H. pylori-induced gastritis has been reported to progress to
gastric cancer [25], the intake of AN may affect gastric
carcinogenesis induced by H. pylori infection. Since there
was no significant difference in the extent of H. pylori
bacterial colonization between groups ND/HP and AD/HP,
the more severe chronic gastric inflammation with more
lymphocyte infiltration in AD/HP was most likely
aggravated by the effect of AN itself and not by the
differential colonization of H. pylori.
Recently, Ji et al. [18] reported that AN induced DNA
damage and expression of inflammatory cytokines such as
IL-6 and IL-8 in oral cancer cells, and these effects were
more prominent on cells cultured in low serum condition
(1% FBS) or serum-free condition than cells cultured in 10%
FBS condition. In addition, it was shown that H. pylori
infection reduced the gastric mucosal blood flow in animal
models [3, 19] and humans [1], which may resemble the
low serum condition. This would be a potential mechanism
for the exacerbating gastric inflammation induced by
H. pylori infection.
Further studies will be needed to determine the main
pathway related to the progression of gastric inflammation
with AN intake. In addition, this animal model is useful for
the experiments to determine the effect of potential
carcinogens on H. pylori-induced gastric lesions. In
Fig. 4. Effect of areca nut on H. pylori-induced gastric lesions in mice. 
(A) The corpus part of the gastric mucosa was stained with hematoxylin and eosin, and microscopic images were obtained (magnification of ×100).
(B) The antrum part of the gastric mucosa was stained with hematoxylin and eosin, and microscopic images were obtained (magnification ×200).
(C, D) Histological grading of the PMN infiltration (C) and of lymphocyte infiltration (D) in the gastric mucosa. Inflammatory responses of the
gastric mucosa were graded according to morphological criteria. * indicates a significant difference at p < 0.05.
1822 Lee et al.
J. Microbiol. Biotechnol.
conclusion, AN induced severer chronic gastritis infection
with the H. pylori PMSS1 strain, and the chewing of betel
quid containing AN may predispose those infected with
H. pylori to severe gastric diseases, including gastric cancers.
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